BRIMONIDINE TARTRATE | N208144 | BAUSCH AND LOMB INC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2024-00563 | 11596600 | IPR | Dr. Reddy's Laboratories S.A. et al. | Terminated-Settled | 2024-02-21 | 2024-09-10 |
| IPR2024-00467 | 11833245 | IPR | Dr. Reddy's Laboratories S.A. et al. | Terminated-Settled | 2024-01-24 | 2025-07-22 |
| IPR2022-00142 | 8293742 | IPR | Slayback Pharma LLC et al. | Terminated-Settled | 2021-11-04 | 2025-08-13 |
| IPR2022-00146 | 9259425 | IPR | Slayback Pharma LLC | Terminated-Settled | 2021-11-04 | — |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BAUSCH & LOMB INC. et al v. GRANULES INDIA LTD. 4 patentsANDA 220937brimonidine tartrate | D.N.J. | 2025-12-09 | Active | — |
BAUSCH & LOMB INC. et al v. SOMERSET THERAPEUTICS, LLC et al 4 patentsANDA 219823Brimonidine Tartrate | D.N.J. | 2025-04-28 | Terminated 2026-01-12 | — |
BAUSCH & LOMB INC. et al v. GLAND PHARMA LIMITED 4 patentsANDA 220091Brimonidine Tartrate | D.N.J. | 2025-04-28 | Terminated 2025-12-23 | — |
| D.N.J. | 2022-02-02 | Terminated 2022-12-05 | — | |
BAUSCH & LOMB, INC. et al v. SLAYBACK PHARMA LLC et al 2 patentsANDA 216361Brimonidine tartrate | D.N.J. | 2021-09-10 | Terminated 2024-11-27 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$3.45
per ml
Lowest NADAC/Unit
$2.00
per ml
Brand NDCs
2
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 24208053708LUMIFY 0.025% EYE DROP | $3.45 | ML | Brand | — | 2026-05-20 |
| 24208053725LUMIFY 0.025% EYE DROP | $2.00 | ML | Brand | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.